Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
01 Mar 2018 Endocrinopathies Induced by Immune Checkpoint Inhibitor Regimens Cancer Immunology and Immunotherapy
28 Feb 2018 FDA Approves Abemaciclib as Initial Therapy for HR-positive HER2-negative Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
27 Feb 2018 EMA Adopts a Negative Opinion for Extension of Indications for Sunitinib Genitourinary cancers - Anticancer agents & Biologic therapy
26 Feb 2018 EMA Recommends Refusal of the Marketing Authorisation for Neratinib Breast cancer - Anticancer agents & Biologic therapy
23 Feb 2018 Adherence to Follow-up is Low in Adolescent and Young Adult Cancer Survivors Cancer in Special Situations / Population
22 Feb 2018 High Body Fat Level Is Associated With Increased Risk of ER-Positive Breast Cancer in Postmenopausal Women Even With Normal BMI Breast cancer - Epidemiology/Etiology/Cancer Prevention
21 Feb 2018 FDA Approves Durvalumab After Chemoradiation for Unresectable Stage III NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
20 Feb 2018 NICE Updates Medical Technologies Guidance on PleurX Peritoneal Catheter Drainage System Palliative and supportive care
19 Feb 2018 Neoadjuvant Dabrafenib/Trametinib for High-Risk, Surgically Resectable BRAF-Mutated Melanoma Melanoma and other skin tumours - Personalised medicine - Anticancer agents & Biologic therapy
16 Feb 2018 FDA Approves Apalutamide for Non-Metastatic Castration-Resistant Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
15 Feb 2018 Promises from in Situ Vaccination Basic science - Cancer Immunology and Immunotherapy
14 Feb 2018 Phase III IMmotion151 Study Met Its Co-Primary Endpoint of Investigator-Assessed PFS Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
13 Feb 2018 FDA Approves the RadioGenix System for Producing Technetium-99m Diagnosis, Imaging and Staging
12 Feb 2018 CancerSEEK Promises Earlier Detection of Cancer Translational research
09 Feb 2018 FDA Approves Abiraterone Acetate in Combination with Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy